Papers
1
Total Citations
4
H-Index
1
About
Dr. Dongkui Song is a prominent urologic oncologist whose research centers on improving surgical outcomes for bladder cancer patients. His most impactful work involves large-scale, multicenter investigations comparing minimally invasive and open surgical approaches. Notably, his landmark study on survival after radical cystectomy, conducted through the Chinese Bladder Cancer Consortium, provides critical evidence on oncological outcomes for patients undergoing either minimally invasive radical cystectomy (MIRC) or open radical cystectomy (ORC). This comparative effectiveness research, which has garnered significant attention with 4 citations, directly informs clinical decision-making and surgical best practices. Dr. Song’s contributions are vital in advancing urologic oncology, particularly in optimizing treatment strategies for bladder cancer. His collaborative, data-driven approach has established him as a key figure in the field, helping to shape the future of surgical care and improve patient survival rates.
Research Focus
Key Achievements
Top Papers
- 1